Factors Predicting Microinvasion in Ductal Carcinoma in situ |
Ozkan-Gurdal, Sibel
(Department of Surgery, School of Medicine, Namik Kemal University)
Cabioglu, Neslihan (Department of Surgery, Istanbul Medical Faculty, Istanbul University) Ozcinar, Beyza (Department of Surgery, Istanbul Medical Faculty, Istanbul University) Muslumanoglu, Mahmut (Department of Surgery, Istanbul Medical Faculty, Istanbul University) Ozmen, Vahit (Department of Surgery, Istanbul Medical Faculty, Istanbul University) Kecer, Mustafa (Department of Surgery, Istanbul Medical Faculty, Istanbul University) Yavuz, Ekrem (Departments of Pathology, Istanbul Medical Faculty, Istanbul University) Igci, Abdullah (Department of Surgery, Istanbul Medical Faculty, Istanbul University) |
1 | Intra M, Rotmensz N, Veronesi P, et al (2008). Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast. Ann Surg, 247, 315-9. DOI ScienceOn |
2 | Zavagno G, Belardinelli V, Marconato R, et al(2007). Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion. Breast, 16, 146-51. DOI ScienceOn |
3 | Houghton J, George WD, Cuzick J (2003). Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet, 362, 95-102. DOI ScienceOn |
4 | Greenlee RT, Hill-Harmon MB, Murray T, et al (2001). Cancer statistics 2001. CA Cancer J Clin, 51, 15-36. DOI ScienceOn |
5 | Ikeda DM, Andersson I (1989). Ductal carcinoma in situ: atypical mammographic appearances. Radiology, 172, 661-6. DOI |
6 | Intra M, Zurrida S, Maffini F, et al (2003). Sentinel lymph node metastasis in microinvasive breast cancer. Ann Surg Oncol, 10, 1160-5. DOI |
7 | Katz A, Gage I, Evans S, et al (2006).Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg, 191, 761-6. DOI ScienceOn |
8 | Wilkie C, White L, Dupont E, et al (2005). An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Am J Surg, 190, 563-6. DOI ScienceOn |
9 | Winchester DP, Menck HR, Osteen RT, et al (1995). Treatment trends for ductal carcinoma in situ of the breast. Ann Surg Oncol, 2, 207-13. DOI |
10 | Yen TW, Hunt KK, Ross MI, et al (2005). Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg, 200, 516-26. DOI ScienceOn |
11 | Yu KD, Wu LM, Liu GY, et al (2011). Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component. Ann Surg Oncol, 18, 1342-8. DOI |
12 | Cutuli B, Cohen-Solal-Le Nir C, De Lafontan B, et al (2001). Ductal carcinoma in situ of the breast results of conservative and radical treatments in 716 patients. Eur J Cancer, 37, 2365-72. DOI ScienceOn |
13 | Baxter NN, Virnig BA, Durham SB, et al (2004). Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst, 96, 443-8. DOI ScienceOn |
14 | Boyages J, Delaney G, Taylor R (1999). Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Cancer, 85, 616-28. DOI |
15 | Cavaliere A, Scheibel M, Bellezza G, et al (2006). Ductal carcinoma in situ with microinvasion: clinicopathologic study and biopathologic profile. Pathol Res Pract, 202, 131-5. DOI ScienceOn |
16 | Adlard JW, Bundred NJ (2006). Radiotherapy for ductal carcinoma in situ. Clin Oncol, 18, 179-84. DOI ScienceOn |
17 | Altintas S, Lambein K, Huizing MT, et al (2009). Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study. Breast J, 15, 120-32. DOI ScienceOn |
18 | Edge SB, Byrd DR, Compton CC, et al (2009). AJCC Cancer Staging Handbook, seventh edition. Chicago: Springer, pp419-60. |
19 | Daly MB (2006). Tamoxifen in ductal carcinoma in situ. Semin Oncol, 33, 647-9. DOI ScienceOn |
20 | Dershaw DD, Abramson A, Kinne DW (1989). Ductal carcinoma in situ: mammographic findings and clinical implications. Radiology, 170, 411-5. DOI |
21 | Ernster VL, Barclay J, Kerlikowske K, et al (1996). Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA, 275, 913-8. DOI ScienceOn |
22 | Fisher B, Dignam J, Wolmark N, et al (1998). Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from national surgical adjuvant breast and bowel project B-17. J Clin Oncol, 16, 441-52. |
23 | Silverstein MJ, Lagios MD, Groshen S, et al (1999). The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med, 340, 1455-61. DOI ScienceOn |
24 | Sakr R, Barranger E, Antoine M, et al (2006). Ductal carcinoma in situ: value of sentinel lymph node biopsy. J Surg Oncol, 94, 426-30. DOI ScienceOn |
25 | Silver SA, Tavassoli FA (1998). Mammary ductal carcinoma in situ with microinvasion. Cancer, 82, 2382-90. DOI |
26 | Silverstein MJ (2003). The University of Southern California/ Van Nuys prognostic index for DCIS of the breast. Am J Surg, 186, 337-43. DOI ScienceOn |
27 | Silverstein M, Skinner K, Lomis T (2001). Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg, 25, 767-72. DOI ScienceOn |
28 | Tan JC, McCready DR, Easson AM, et al (2007). Role of sentinel lymph node biopsy in ductal carcinoma in-situ treated by mastectomy. Ann Surg Oncol, 14, 638-45. DOI |
29 | Silverstein MJ, Waisman JR, Gamagani P, et al (1990). Intraductal carcinoma of the breast (208 cases). Clinical factors influencing treatment of choice. Cancer, 66, 102-8. DOI |
30 | Skinner KA, Silverstein MJ (2001). The management of ductal carcinoma in situ of the breast. Endocr Relat Cancer, 8, 33-45. DOI ScienceOn |
31 | Vieira CC, Mercado CL, Cangiarella JF, et al (2010). Microinvasive ductal carcinoma in situ: Clinical presentation, imaging features, pathologic findings, and outcome. Eur J Radiol, 73, 102-7. DOI ScienceOn |
32 | Wei Z, Er-li G, Yi-li Z, et al (2012). Different distribution of breast ductal carcinoma in situ, ductal carcinoma in situ with microinvasion, and invasion breast cancer. World J Surg Oncol, 10, 262. DOI |
33 | Anderson B (2000). Axillary metastases with DCIS: is the glass half empty or half full? Ann Surg Oncol, 7, 631-3. DOI ScienceOn |
34 | Ozmen V, Karanlik H, Cabioglu N, et al (2006). Factors predicting the sentinel and non-sentinel lymph node metastases in breast cancer. Breast Cancer Res Treat, 95, 1-6. DOI |
35 | Lagios MD, Margolin FR, Westdahl PR, et al (1989). Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer, 63, 618-24. DOI |
36 | Mirza NQ, Vlastos G, Meric F, et al (2000). Ductal carcinoma in situ: long term results of breast-conserving therapy. Ann Surg Oncol, 7, 656-64. DOI ScienceOn |
37 | Mabry H, Giuliano AE, Silverstein MJ (2006). What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ? Am J Surg, 192, 455-7. DOI ScienceOn |
38 | Park SY, Lee HE, Li H, et al (2010). Heterogeneity for stem cellrelated markers according to tumor subtype and histologic stage in breast cancer. Clin Cancer Res, 16, 876-87. DOI |
39 | Roses RE, Paulson C, Sharma A, et al (2009). HER-2/neu overexpression as a predictor for the transition from in situ to invasive breast cancer. Cancer Epidemiol Biomarkers Prev, 18, 1386-9. DOI ScienceOn |
40 | Rosner D, Bedwani RN, Vana J, et al (1980). Noninvasive breast carcinoma: results of a national survey by the American College of surgeons. Ann Surg, 192, 139-47. DOI ScienceOn |
![]() |